chr7:140753335:> Detail (hg38) (BRAF)

Information

Genome

Assembly Position
hg19 chr7:140,453,135-140,453,137 
hg38 chr7:140,753,335-140,753,337

HGVS

Type Transcript Protein
Summary

MGeND

Clinical significance
Variant entry
GWAS entry
Disease area statistics Show details

Frequency

[No Data.]

Prediction

[No Data.]

ClinVar

Clinical Significance
Review star [No Data.]
Show details
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
Disease Drug EL ET ED CS VO TR Pubmed Links
melanoma Dabrafenib C Predictive Supports Sensitivity/Response Somatic 3 23031422 Detail
DisGeNET
[No Data.]
Annotation

Annotations

DescrptionSourceLinks
A single patient with BRAF V600E/V600M bi-allelic mutation responded to the V600E drug dabrafenib. CIViC Evidence Detail

Overlapped Transcript Coordinates

Gene Transcript ID Exon Number Chromosome Start Stop Type Amino Mutation Transcript Position Links

Overlapped Transcript

Gene Transcript ID Chromosome Start Stop Links
Gene
-
Genome
hg38
Position
chr7:140,753,335-140,753,337
Variant Type
snv
Variant (CIViC) (CIViC Variant)
V600E+V600M
Transcript 1 (CIViC Variant)
ENST00000288602.6
Variant URL (CIViC Variant)
https://civic.genome.wustl.edu/links/variants/13
Summary (CIViC Variant)
A case study of a single patient harboring both a V600E and a V600M mutation, dabrafenib was shown to acheive clinical response.
Variant (CIViC) (CIViC Variant)
V600G
Variant URL (CIViC Variant)
https://civic.genome.wustl.edu/links/variants/1199
Variant (CIViC) (CIViC Variant)
V600L
Variant URL (CIViC Variant)
https://civic.genome.wustl.edu/links/variants/1404
Variant (CIViC) (CIViC Variant)
V600M
Variant URL (CIViC Variant)
https://civic.genome.wustl.edu/links/variants/1405
Genome browser